Jiachen Liu

2.5k total citations · 2 hit papers
101 papers, 1.6k citations indexed

About

Jiachen Liu is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiachen Liu has authored 101 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 20 papers in Immunology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiachen Liu's work include Epigenetics and DNA Methylation (10 papers), Extracellular vesicles in disease (7 papers) and Cancer-related gene regulation (6 papers). Jiachen Liu is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Extracellular vesicles in disease (7 papers) and Cancer-related gene regulation (6 papers). Jiachen Liu collaborates with scholars based in China, United States and United Kingdom. Jiachen Liu's co-authors include Gaiqing Wang, Qinqin Bai, Lirong Liu, Lin Gao, Qiguang Miao, Ying Cao, Rundong Jiang, Jiaqi Xu, Yuezhong Zhang and Lijun Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Jiachen Liu

87 papers receiving 1.6k citations

Hit Papers

Interaction of Microglia and Astrocytes in the Neurovascu... 2020 2026 2022 2024 2020 2025 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiachen Liu China 20 576 339 215 191 168 101 1.6k
Di Zhong China 23 640 1.1× 347 1.0× 246 1.1× 107 0.6× 240 1.4× 72 1.5k
Aijun Liu China 22 564 1.0× 241 0.7× 196 0.9× 127 0.7× 153 0.9× 104 1.9k
Jie Pan China 20 545 0.9× 398 1.2× 165 0.8× 174 0.9× 151 0.9× 78 1.9k
Mengqi Yang China 24 616 1.1× 187 0.6× 142 0.7× 94 0.5× 159 0.9× 114 1.8k
Xiaotong Wang China 27 843 1.5× 164 0.5× 111 0.5× 182 1.0× 185 1.1× 173 2.5k
Chaeyoung Lee South Korea 27 583 1.0× 161 0.5× 183 0.9× 145 0.8× 195 1.2× 160 2.2k
Jianan Lü China 25 704 1.2× 666 2.0× 321 1.5× 452 2.4× 166 1.0× 60 2.0k
Ting Shen China 27 495 0.9× 182 0.5× 87 0.4× 136 0.7× 88 0.5× 137 2.3k
Xiao Z. Shen United States 28 707 1.2× 223 0.7× 328 1.5× 81 0.4× 65 0.4× 67 2.4k

Countries citing papers authored by Jiachen Liu

Since Specialization
Citations

This map shows the geographic impact of Jiachen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiachen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiachen Liu more than expected).

Fields of papers citing papers by Jiachen Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiachen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiachen Liu. The network helps show where Jiachen Liu may publish in the future.

Co-authorship network of co-authors of Jiachen Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiachen Liu. A scholar is included among the top collaborators of Jiachen Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiachen Liu. Jiachen Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qingjiang, et al.. (2025). Antimicrobial diterpenoids from Rosmarinus officinalis. Steroids. 217. 109589–109589. 1 indexed citations
2.
Liu, Jiachen, et al.. (2025). Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications. MedComm. 6(9). e70349–e70349. 1 indexed citations
3.
Liu, Jiachen, et al.. (2025). Long-term impact of per- and polyfluoroalkyl substances on kidney health: a large-scale genetic study. Environmental Sciences Europe. 37(1).
4.
Liu, Jiachen, et al.. (2025). Molecular characterization and functional prioritization of CD46, IL6R, KLRC1, LEAP2 and SMOX as candidate targets in acute kidney injury. International Journal of Biological Macromolecules. 320(Pt 4). 146096–146096.
5.
Liu, Jiachen, Zhen Shi, Yajian Li, et al.. (2025). High-resolution transcriptome atlas of bladder cancer highlights the functional myeloid subsets in modulating immune microenvironment. EBioMedicine. 117. 105801–105801. 1 indexed citations
6.
Chen, Tianyi, et al.. (2025). Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer. Journal of Inflammation Research. Volume 18. 925–947. 7 indexed citations
7.
Liang, Weijun, et al.. (2025). m6A-mediated regulation of CPSF6 by METTL3 promotes oxaliplatin resistance in colorectal cancer through enhanced glycolysis. Cellular Signalling. 130. 111676–111676. 2 indexed citations
8.
Liu, Jiachen, Yi Li, & Ning Tang. (2024). Enhanced solubility and calcium absorption of calcium gluconate and calcium citrate in the presence of aspartic acid and glutamic acid. Journal of Molecular Liquids. 410. 125573–125573. 6 indexed citations
9.
Liu, Jiachen, et al.. (2024). FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway. Scientific Reports. 14(1). 29411–29411. 2 indexed citations
10.
Xu, Qingjiang, et al.. (2024). Triterpene esters of cirsium setosum and their anti-inflammatory activity. Journal of Asian Natural Products Research. 26(8). 892–899.
11.
Li, Weili, Silin Chen, Jiangning Chen, et al.. (2024). Alleviation of colitis by honeysuckle MIR2911 via direct regulation of gut microbiota. Journal of Controlled Release. 376. 123–137. 22 indexed citations
14.
Lv, Jiaoyan, Jie Ma, Jiachen Liu, et al.. (2023). Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis. Frontiers in Immunology. 14. 1230266–1230266. 27 indexed citations
15.
Zhou, Yong, et al.. (2023). Advances in MicroRNA Therapy for Heart Failure: Clinical Trials, Preclinical Studies, and Controversies. Cardiovascular Drugs and Therapy. 39(1). 221–232. 17 indexed citations
16.
Li, Hui, Danyang Liu, Wan‐Qiang Lv, et al.. (2022). Network-Based Approach to Repurpose Approved Drugs for COVID-19 by Integrating GWAS and Text Mining Data. Processes. 10(2). 326–326. 2 indexed citations
17.
Liu, Jiachen, et al.. (2022). Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integration. Journal of Translational Medicine. 20(1). 604–604. 18 indexed citations
18.
Liu, Jiachen, et al.. (2022). Association between CILP and IL-1α polymorphisms and phenotype-dependent intervertebral disc degeneration susceptibility: A meta-analysis. Frontiers in Genetics. 13. 1005393–1005393. 1 indexed citations
19.
Liu, Jiachen, et al.. (2021). Blood Immune Cell Composition Associated with Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis. Frontiers in Pharmacology. 12. 714643–714643. 1 indexed citations
20.
Jiang, Rundong, et al.. (2021). Ligustrazine Alleviate Acute Lung Injury Through Suppressing Pyroptosis and Apoptosis of Alveolar Macrophages. Frontiers in Pharmacology. 12. 680512–680512. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026